High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer.
about
Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorshipGenotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations.The landscape of candidate driver genes differs between male and female breast cancer.Male breast carcinoma: increased awareness needed.Obesity and male breast cancer: provocative parallels?Comparison of whole genome amplification methods for analysis of DNA extracted from microdissected early breast lesions in formalin-fixed paraffin-embedded tissueOncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplificationGene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.An international comparison of male and female breast cancer incidence ratesPromoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification.Expression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancerHMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes.The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer.PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer.Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations.The cancer genetics and pathology of male breast cancer.Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer.Copy number profiling by array comparative genomic hybridization identifies frequently occurring BRCA2-like male breast cancer.Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes.Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression.The Genomic Landscape of Male Breast Cancers.Molecular subtyping of male breast cancer by immunohistochemistry.Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact.Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes.High proliferation is associated with inferior outcome in male breast cancer patients.Flow cytometric DNA hypertetraploidy tends to be more frequent in male than in female breast cancers.Fibrotic focus and hypoxia in male breast cancer.Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancerGhrelin expression is associated with a favorable outcome in male breast cancer
P2860
Q27025244-0AF82F29-3F69-42A0-BCDB-8277126481F2Q34475135-F65881AD-5EC6-4307-806B-C095C38C6FA5Q34686985-A1948F5A-9410-4B3B-8823-659B6E246831Q35032523-DD565822-35EC-48AB-ACFC-7ED7490F5E02Q35683518-C148036F-9776-44E0-959E-A1133A70B78DQ35687528-FCAC3AB8-4E87-4D47-8FD8-4D353A14D858Q35864247-9864C3F4-286E-42E7-8187-D7AE5AD9F7F1Q36147178-C4A507CF-CD51-4C32-A3BC-DA761C5475E0Q36393217-4AAF149E-B86D-4DAD-972D-FB6D8D0C5885Q36557024-803B8A1C-63CC-4869-84C4-80B0E99B11C9Q36924432-602872A5-AA89-4FC5-AF3A-2FB565A982B4Q37151073-735B6B09-7CE0-4F0F-BA0D-D039AC55FDE6Q37319005-92AEEA7E-5E72-41B1-9EA0-2F9134FE7364Q37536519-0973A888-4002-4A68-8627-0B5C3104963BQ37690197-2C15EAC8-B574-4F01-B977-33EF8E6F5C27Q38239410-85B05E17-2EB3-477E-B47B-72BBCD90B70DQ38696800-A512161A-BA1C-4605-A228-DF4BA75F7BF5Q40420136-51657660-56F2-4118-A6DC-450AFCE1E94FQ40556065-EF0E0304-8779-4EA7-99DB-8C16BFF86539Q41136382-505A145A-B958-4756-A4F6-061C8D500792Q41388351-7E80E65A-B338-4A95-8165-CB1F5015F309Q41739963-1D9C02E1-5461-4C9A-B4A7-8B101B780302Q42496958-33FB3088-F166-4632-A260-724CA72B76EDQ42511904-17A3B0CA-877D-45CA-8B0A-93F8EDC199F6Q42516409-85092FB9-3426-46AA-87DB-14F79ED66C74Q46532481-ACCB6D49-2763-4071-89C9-423C1786F3DDQ51071354-CEE1E2FD-2EC6-4243-8848-69E96E436846Q51333044-5EAD49A0-2442-4E6C-9802-F215DF344679Q58709910-A1BBE0A8-BD9A-4102-9C0C-59C74E72863CQ58751760-011BE664-4A1E-47AB-84BD-A5B9B79B8D18
P2860
High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High-resolution genomic profil ...... ies with female breast cancer.
@ast
High-resolution genomic profil ...... ies with female breast cancer.
@en
type
label
High-resolution genomic profil ...... ies with female breast cancer.
@ast
High-resolution genomic profil ...... ies with female breast cancer.
@en
prefLabel
High-resolution genomic profil ...... ies with female breast cancer.
@ast
High-resolution genomic profil ...... ies with female breast cancer.
@en
P2093
P2860
P50
P1476
High-resolution genomic profil ...... ies with female breast cancer.
@en
P2093
Carina Strand
Cecilia Nilsson
Göran Jönsson
Ida Johansson
Johan Staaf
Marie-Louise Fjällskog
Pontus Berglund
Rosa B Barkardottir
P2860
P2888
P304
P356
10.1007/S10549-010-1262-8
P407
P577
2010-11-27T00:00:00Z
P5875
P6179
1041308069